Hims & Hers Health gains after company to offer compounded GLP-1 drugs

** Telehealth company Hims & Hers Health HIMS shares rise 12.49% to $16.39

** Company to offer compounded GLP-1 weight loss injections, in addition to weight management oral medication kits

** Pricing starts at $79 per month for oral medication kits and at $199 per month for compounded GLP-1 injections, which includes unlimited medical consultations with a licensed provider

** HIMS plans to make branded GLP-1 medications available

** The U.S. FDA had previously raised concerns about the prevalence of compounded and fake versions of highly in demand new weight loss drugs online

** Extremely popular drugs such as Novo Nordisk's NOVO_B Ozempic and Wegovy and Eli Lilly's LLY Mounjaro and Zepbound belong to the class of drugs known as GLP-1 agonists, which mimic the activity of a hormone that slows digestion and helps people feel full for longer

** HIMS stock up ~63% YTD